FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Novartis Reports Favorable Data on Kidney Drug

Novartis reports favorable data from a pre-specified interim analysis of the Phase 3 APPLAUSE-IgAN study of early kidney failure indirect surrogate ma...

Medical Devices

FDA Clears 3D Printed Cranial Implant

FDA clears a 3D Systems 510(k) for its 3D-printed, patient-specific cranial implant VSP PEEK Cranial Implant and its use in restoring skull defects.

latest-news-card-1
Human Drugs

FDA Inspection Hits Zydus With Form-483

FDA issues Zydus Lifesciences a four-item Form FDA-483 after inspecting the firms manufacturing facility (Matoda, Gujarat, India).

latest-news-card-1
Human Drugs

Orphan Status for Ebola-like Vaccine

FDA grants Soligenix an orphan drug designation for the active ingredient in MarVax vaccine against MARV infection.

latest-news-card-1
Medical Devices

HeartMate Pumps Recalled Due to Obstructions

Abbotts Thoratec unit recalls its HeartMate II and HeartMate 3 Left Ventricular Assist System due to an issue called extrinsic outflow graft obstructi...

latest-news-card-1
Human Drugs

CDER Launches Trial Innovation Center

CDER announces the launch of its Center for Clinical Trial Innovation, which will focus on promoting clinical trial innovation activities through enha...

latest-news-card-1
Medical Devices

Fresenius Recalls Infusion Pump Software

Fresenius Kabi USA recalls (Class 1) its large-volume pump software of the Ivenix Infusion System due to software anomalies that have the potential to...

latest-news-card-1
Human Drugs

Sun Gets OAI Inspection at India Facility

FDA classifies a December inspection at Sun Pharmaceutical Industries Dadra, India facility as official action indicated.

latest-news-card-1
Human Drugs

Panel Backs Minimal Residual Disease Endpoint

FDAs Oncologic Drugs Advisory Committee unanimously votes (12 to 0) that the totality of data are adequate to support the use of minimal residual dise...

latest-news-card-1
Biologics

Enlivex Mixed Results of Sepsis Cell Therapy

Enlivex Therapeutics reports mixed results from its Phase 2 study of Allocetra in patients with sepsis.